Your browser doesn't support javascript.
loading
Recent Progress of Tertiary Lymphoid Structure in Prognosis and Immunotherapy of Non-small Cell Lung Cancer / 中国肺癌杂志
Chinese Journal of Lung Cancer ; (12): 615-620, 2023.
Artículo en Chino | WPRIM | ID: wpr-1010067
ABSTRACT
Lung cancer is the leading cause of cancer death, and non-small cell lung cancer (NSCLC) accounts for 85%. Immunotherapy has significantly improved the clinical prognosis of patients with NSCLC. However, because of the complexity and heterogeneousness of the tumor microenvironment, only a subset of individuals can benefit from immunotherapy. Therefore, it is necessary to explore effective predictive biomarkers for immunotherapy of NSCLC. Tertiary lymphoid structure (TLS) is an ectopic lymphoid organ that is highly similar to secondary lymphoid organs (SLO), and the presence of TLS has been found to be closely associated with a good prognosis in immunotherapy for a variety of solid tumors, including NSCLC. This article provides a review of the prognostic role of tertiary lymphoid structures in immunotherapy of NSCLC, in order to offer references for screening suitable candidates for immunotherapy of NSCLC and develop personalized and precise treatment plans.
.
Asunto(s)

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Pronóstico / Carcinoma de Pulmón de Células no Pequeñas / Microambiente Tumoral / Estructuras Linfoides Terciarias / Inmunoterapia / Neoplasias Pulmonares Límite: Humanos Idioma: Chino Revista: Chinese Journal of Lung Cancer Año: 2023 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Pronóstico / Carcinoma de Pulmón de Células no Pequeñas / Microambiente Tumoral / Estructuras Linfoides Terciarias / Inmunoterapia / Neoplasias Pulmonares Límite: Humanos Idioma: Chino Revista: Chinese Journal of Lung Cancer Año: 2023 Tipo del documento: Artículo